The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...

While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

A spokesperson confirmed the company plans to reduce its workforce by “less than 20%,” months after significantly lowering ...